{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:12:50Z","timestamp":1789503170929,"version":"build-2803163510"},"reference-count":274,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the definition recently proposed to better circumscribe the spectrum of conditions long known as non-alcoholic fatty liver disease (NAFLD) that range from simple steatosis without inflammation to more advanced liver diseases. The progression of MAFLD, as well as other chronic liver diseases, toward cirrhosis, is driven by hepatic inflammation and fibrogenesis. The latter, result of a \u201c<jats:italic>chronic wound healing reaction<\/jats:italic>,\u201d is a dynamic process, and the understanding of its underlying pathophysiological events has increased in recent years. Fibrosis progresses in a microenvironment where it takes part an interplay between fibrogenic cells and many other elements, including some cells of the immune system with an underexplored or still unclear role in liver diseases. Some therapeutic approaches, also acting on the immune system, have been probed over time to evaluate their ability to improve inflammation and fibrosis in NAFLD, but to date no drug has been approved to treat this condition. In this review, we will focus on the contribution of the liver immune system in the progression of NAFLD, and on therapies under study that aim to counter the immune substrate of the disease.<\/jats:p>","DOI":"10.3389\/fmed.2021.781567","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T10:40:21Z","timestamp":1639046421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":42,"title":["Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System"],"prefix":"10.3389","volume":"8","author":[{"given":"Pietro","family":"Torre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta Maria","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Sciorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Masarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Persico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology."},{"key":"B2","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc."},{"key":"B3","first-page":"283","article-title":"Nonalcoholic fatty liver disease","volume":"8","author":"Schaffner","year":"1986","journal-title":"Prog Liver Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clinical Liver Disease."},{"key":"B7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e00112","DOI":"10.1002\/edm2.112","article-title":"The metabolic basis of nonalcoholic steatohepatitis","volume":"3","author":"Chakravarthy","year":"2020","journal-title":"Endocrinol Diabetes Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S2468-1253(17)30146-2","article-title":"Is it time to change NAFLD and NASH nomenclature?","volume":"2","author":"Bellentani","year":"2017","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study","volume":"67","author":"Allen","year":"2018","journal-title":"Hepatology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00000441-200503000-00001","article-title":"Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third national health and nutrition survey (NHANES III)","volume":"329","author":"Liangpunsakul","year":"2005","journal-title":"Am J Med Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"Ma","year":"2017","journal-title":"J Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?","volume":"230","author":"Oni","year":"2013","journal-title":"Atherosclerosis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: A membrane trafficking machine","volume":"218","author":"Schulze","year":"2019","journal-title":"J Cell Biol."},{"key":"B19","volume-title":"The Liver as a Lymphoid Organ, in Liver Immunology: Principles and Practice","author":"Lian","year":"2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2007.08.002","article-title":"Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran","volume":"130","author":"Kim","year":"2007","journal-title":"Cell."},{"key":"B21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-immunol-051116-052415","article-title":"Immune responses in the liver","volume":"36","author":"Kubes","year":"2018","journal-title":"Annu Rev Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/eji.200738060","article-title":"Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells","volume":"38","author":"Schildberg","year":"2008","journal-title":"Eur J Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.21965","article-title":"Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance","volume":"47","author":"Diehl","year":"2008","journal-title":"Hepatology."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/82161","article-title":"Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance","volume":"6","author":"Limmer","year":"2000","journal-title":"Nat Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"Crispe","year":"2006","journal-title":"Immunol Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells - gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jhep.2014.04.027","article-title":"TGF-\u03b2-dependent induction of CD4?CD25?Foxp3? Tregs by liver sinusoidal endothelial cells","volume":"61","author":"Carambia","year":"2014","journal-title":"J Hepatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/j.1478-3231.2006.01325.x","article-title":"Endotoxin tolerance in human intrahepatic biliary epithelial cells is induced by upregulation of IRAK-M","volume":"26","author":"Harada","year":"2006","journal-title":"Liver Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/hep.24352","article-title":"Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism","volume":"54","author":"Schildberg","year":"2011","journal-title":"Hepatology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1038\/cti.2016.51","article-title":"MAIT cells: new guardians of the liver","volume":"5","author":"Kurioka","year":"2016","journal-title":"Clin Transl Immunology."},{"key":"B32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-mediated adaptive immune tolerance","volume":"10","author":"Zheng","year":"2019","journal-title":"Front Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/223472a0","article-title":"Induction of immunological tolerance by porcine liver allografts","volume":"223","author":"Calne","year":"1969","journal-title":"Nature."},{"key":"B35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/226366a0","article-title":"Anti HL-A2 Inhibitor in Normal Human Serum","volume":"226","author":"Van Rood","year":"1970","journal-title":"Nature."},{"key":"B36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1055\/s-2007-979471","article-title":"The liver: a special case in transplantation tolerance","volume":"27","author":"Benseler","year":"2007","journal-title":"Semin Liver Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ","volume":"27","author":"Crispe","year":"2009","journal-title":"Ann Rev Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"G620","DOI":"10.1152\/ajpgi.00314.2003","article-title":"Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species","volume":"287","author":"Uchikura","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-0528.2002.017412.x","article-title":"The liver as a site of T-cell apoptosis: graveyard, or killing field?","volume":"174","author":"Crispe","year":"2000","journal-title":"Immunol Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/cmi.2013.7","article-title":"The liver works as a school to educate regulatory immune cells","volume":"10","author":"Li","year":"2013","journal-title":"Cell Mol Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jaut.2017.08.005","article-title":"The differential organogenesis and functionality of two liver-draining lymph nodes in mice","volume":"84","author":"Yu","year":"2017","journal-title":"J Autoimmunity."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor Farnesoid x receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","article-title":"A guide to immunometabolism for immunologists","volume":"16","author":"O'Neill","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","article-title":"HIF-1alpha is essential for myeloid cell-mediated inflammation","volume":"112","author":"Cramer","year":"2003","journal-title":"Cell."},{"key":"B47","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2006.05.011","article-title":"Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation","volume":"4","author":"Vats","year":"2006","journal-title":"Cell Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41556-018-0217-x","article-title":"Metabolism as a guiding force for immunity","volume":"21","author":"Jung","year":"2019","journal-title":"Nat Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology."},{"key":"B54","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/jgh.13058","article-title":"Small intestinal bacterial overgrowth and toll-like receptor signaling in patients with non-alcoholic fatty liver disease","volume":"31","author":"Kapil","year":"2016","journal-title":"J Gastroenterol Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","article-title":"Genetics and epigenetics of NAFLD and NASH: Clinical impact","volume":"68","author":"Eslam","year":"2018","journal-title":"J Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","article-title":"Genetic and epigenetic factors determining NAFLD risk","volume":"50","author":"Jonas","year":"2021","journal-title":"Mol Metab."},{"key":"B59","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1053\/j.gastro.2013.07.047","article-title":"Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease","volume":"145","author":"Murphy","year":"2013","journal-title":"Gastroenterology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/nu13041314","article-title":"The role of fructose in non-alcoholic steatohepatitis: old relationship and new insights","volume":"13","author":"Federico","year":"2021","journal-title":"Nutrients."},{"key":"B62","doi-asserted-by":"publisher","first-page":"E1440","DOI":"10.1152\/ajpendo.00355.2012","article-title":"Effect of exercise training on metabolic flexibility in response to a high-fat diet in obese individuals","volume":"303","author":"Battaglia","year":"2012","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/ceh.2021.104441","article-title":"Non-alcoholic fatty liver disease and lipotoxicity","volume":"7","author":"Wasilewska","year":"2021","journal-title":"Clin Exp Hepatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol Aspects Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: an overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/egh.09.32","article-title":"Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal","volume":"3","author":"Alkhouri","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","article-title":"Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?","volume":"11","author":"Rada","year":"2020","journal-title":"Cell Death Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor\u2212\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Rad Biol Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"27849","DOI":"10.1038\/srep27849","article-title":"Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease","volume":"6","author":"Kim","year":"2016","journal-title":"Sci Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J Hepatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fmed.2021.595371","article-title":"Oxidative stress in non-alcoholic fatty liver disease. An updated mini review","volume":"8","author":"Delli Bovi","year":"2021","journal-title":"Front Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"10436","DOI":"10.3390\/ijms22010436","article-title":"Immunity as cornerstone of non-alcoholic fatty liver disease: the contribution of oxidative stress in the disease progression","volume":"22","author":"Dallio","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1152\/ajpendo.00492.2015","article-title":"Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity","volume":"310","author":"Patterson","year":"2016","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"9547613","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid Med Cell Longev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/hep.28662","article-title":"Correction: Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes","volume":"64","author":"Ibrahim","year":"2016","journal-title":"Hepatology."},{"key":"B79","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3389\/fphys.2020.00850","article-title":"Lipophagy impairment is associated with disease progression in NAFLD","volume":"11","author":"Carotti","year":"2020","journal-title":"Front Physiol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.copbio.2019.01.005","article-title":"Extracellular vesicles: exosomes, microparticles, their parts, and their targets to enable their biomanufacturing and clinical applications","volume":"60","author":"Kao","year":"2019","journal-title":"Curr Opin Biotechnol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jcmgh.2015.07.007","article-title":"Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-\u03b3","volume":"1","author":"Povero","year":"2015","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1053\/j.gastro.2015.12.037","article-title":"Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes","volume":"150","author":"Hirsova","year":"2016","journal-title":"Gastroenterology."},{"key":"B83","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","article-title":"Mechanisms of hepatic fibrogenesis","volume":"25","author":"Lee","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"72032","DOI":"10.3390\/jcm9072032","article-title":"Role of extracellular vesicles in the pathophysiology, diagnosis and tracking of non-alcoholic fatty liver disease","volume":"9","author":"Newman","year":"2020","journal-title":"J Clin Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"e597648","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv Drug Deliv Rev."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology."},{"key":"B90","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1186\/1471-2407-14-518","article-title":"Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver","volume":"14","author":"Naba","year":"2014","journal-title":"BMC Cancer."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e574276","DOI":"10.3389\/fimmu.2020.574276","article-title":"Immunomodulatory role of the extracellular matrix within the liver disease microenvironment","volume":"11","author":"McQuitty","year":"2020","journal-title":"Front Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.matbio.2017.12.012","article-title":"Matrix metalloproteinases and liver fibrosis (translational aspects)","author":"Roeb","year":"2018","journal-title":"Matrix Biol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/jhep.2002.35625","article-title":"Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse","volume":"36","author":"Yoshiji","year":"2002","journal-title":"Hepatology."},{"key":"B94","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.jhepr.2020.100115","article-title":"The liver matrisome - looking beyond collagens","volume":"2","author":"Arteel","year":"2020","journal-title":"JHEP Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin Liver Dis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1111\/bph.15289","article-title":"Regulation of hepatic stellate cell contraction and cirrhotic portal hypertension by Wnt\/\u03b2-catenin signalling via interaction with Gli1","volume":"178","author":"Zhang","year":"2021","journal-title":"Br J Pharmacol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J Biol Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1055\/s-2005-858989","article-title":"TGF-beta\/Smad signaling in the injured liver","volume":"44","author":"Breitkopf","year":"2006","journal-title":"Z Gastroenterol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0168-8278(99)80010-5","article-title":"The role of TGF\u03b21 in initiating hepatic stellate cell activation in vivo.","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J Hepatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1172\/JCI1112","article-title":"Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine\/paracrine mechanisms involving TGF-beta, PGE2, and PAF","volume":"101","author":"Fadok","year":"1998","journal-title":"J Clin Invest."},{"key":"B102","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/01.LAB.0000069036.63405.5C","article-title":"Apoptotic body engulfment by a human stellate cell line is profibrogenic","volume":"83","author":"Canbay","year":"2003","journal-title":"Lab Investig."},{"key":"B103","doi-asserted-by":"publisher","first-page":"d1720","DOI":"10.2741\/A875","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"Pinzani","year":"2002","journal-title":"Front Biosci."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.4049\/jimmunol.1203013","article-title":"IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation","volume":"191","author":"Tan","year":"2013","journal-title":"J Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tem.2015.01.002","article-title":"Adipocytokines and hepatic fibrosis","volume":"26","author":"Saxena","year":"2015","journal-title":"Trends Endocrinol Metab."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/hep.21867","article-title":"Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9","volume":"46","author":"Watanabe","year":"2007","journal-title":"Hepatology."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","article-title":"Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells","volume":"37","author":"Paik","year":"2003","journal-title":"Hepatology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"aat0344","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci Transl Med."},{"key":"B110","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/path.2888","article-title":"Increased production of sonic hedgehog by ballooned hepatocytes","volume":"224","author":"Rangwala","year":"2011","journal-title":"J Pathol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J Hepatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","article-title":"Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin \u03b1(V)\u03b2(3) engagement and PI3K\/pAkt\/NF\u03baB signaling","volume":"55","author":"Urtasun","year":"2012","journal-title":"Hepatology."},{"key":"B113","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology."},{"key":"B114","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.imlet.2009.09.014","article-title":"LAIR and collagens in immune regulation","volume":"128","author":"Meyaard","year":"2010","journal-title":"Immunol Lett."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/JCI200112373","article-title":"DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells","volume":"108","author":"Olaso","year":"2001","journal-title":"J Clin Invest."},{"key":"B116","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1369\/0022155417740880","article-title":"Danger-associated molecular patterns derived from the extracellular matrix provide temporal control of innate immunity","volume":"66","author":"Frevert","year":"2018","journal-title":"J Histochem Cytochem."},{"key":"B117","doi-asserted-by":"publisher","first-page":"120274","DOI":"10.1172\/jci.insight.120274","article-title":"Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes","volume":"3","author":"Ramnath","year":"2018","journal-title":"JCI Insight."},{"key":"B118","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1038\/s41598-018-25743-8","article-title":"Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD","volume":"8","author":"Zhu","year":"2018","journal-title":"Scientific Reports."},{"key":"B119","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/hepr.12787","article-title":"Role of thrombospondin 1 in liver diseases","volume":"47","author":"Li","year":"2017","journal-title":"Hepatol Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1194\/jlr.M026013","article-title":"CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice","volume":"54","author":"Bian","year":"2013","journal-title":"J Lipid Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.22927","article-title":"Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease","volume":"49","author":"Charlton","year":"2009","journal-title":"Hepatology."},{"key":"B122","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1172\/JCI74438","article-title":"Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPAR\u03b1","volume":"124","author":"Lu","year":"2014","journal-title":"J Clin Investig."},{"key":"B123","doi-asserted-by":"publisher","first-page":"37886","DOI":"10.1038\/srep37886","article-title":"Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects","volume":"6","author":"Yang","year":"2016","journal-title":"Sci Rep."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2019.07.036","article-title":"ECM1 prevents activation of transforming growth factor \u03b2, hepatic stellate cells, and fibrogenesis in mice","volume":"157","author":"Fan","year":"2019","journal-title":"Gastroenterology."},{"key":"B125","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1189\/jlb.0109001","article-title":"Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells","volume":"86","author":"Bollyky","year":"2009","journal-title":"J Leukocyte Biol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"G807","DOI":"10.1152\/ajpgi.00447.2014","article-title":"Novel insights into the function and dynamics of extracellular matrix in liver fibrosis","volume":"308","author":"Karsdal","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"108445","DOI":"10.1016\/j.abb.2020.108445","article-title":"Liver fibrogenesis: un update on established and emerging basic concepts","volume":"689","author":"Novo","year":"2020","journal-title":"Arch Biochem Biophys."},{"key":"B128","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.26598","article-title":"Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver","volume":"59","author":"Guillot","year":"2014","journal-title":"Hepatology."},{"key":"B129","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2012.02.028","article-title":"Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis","volume":"57","author":"Leroux","year":"2012","journal-title":"J Hepatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"490","DOI":"10.3389\/fimmu.2016.00490","article-title":"Immune imbalances in non-alcoholic fatty liver disease: from general biomarkers and neutrophils to interleukin-17 axis activation and new therapeutic targets","volume":"7","author":"Paquissi","year":"2016","journal-title":"Front Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases","volume":"14","author":"Cai","year":"2019","journal-title":"Annu Rev Pathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science."},{"key":"B134","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: A program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science."},{"key":"B136","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci."},{"key":"B138","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/nri.2017.9","article-title":"Dying cells actively regulate adaptive immune responses","volume":"17","author":"Yatim","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B139","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2008.05.013","article-title":"Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein","volume":"29","author":"Kazama","year":"2008","journal-title":"Immunity."},{"key":"B140","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1053\/j.gastro.2010.03.052","article-title":"Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice","volume":"139","author":"Miura","year":"2010","journal-title":"Gastroenterology."},{"key":"B141","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jcmgh.2016.04.007","article-title":"Hepatocyte toll-like receptor 5 promotes bacterial clearance and protects mice against high-fat diet\u2013 induced liver disease","volume":"2","author":"Etienne-Mesmin","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"7381","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J Gastroenterol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"16683","DOI":"10.1074\/jbc.M011695200","article-title":"Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through toll-like receptor 4 *.","volume":"276","author":"Lee","year":"2001","journal-title":"J Biol Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jhep.2013.04.025","article-title":"Food-derived peroxidized fatty acids may trigger hepatic inflammation: A novel hypothesis to explain steatohepatitis","volume":"59","author":"B\u00f6hm","year":"2013","journal-title":"J Hepatol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1194\/jlr.M072454","article-title":"Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH","volume":"58","author":"Ioannou","year":"2017","journal-title":"J Lipid Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/ijms18081649","article-title":"Adipokines and non-alcoholic fatty liver disease: multiple interactions","volume":"18","author":"Adolph","year":"2017","journal-title":"Int J Mol Sci."},{"key":"B147","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/atm.2020.02.184","article-title":"The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis","volume":"8","author":"M\u00e9ndez-S\u00e1nchez","year":"2020","journal-title":"Ann Transl Med."},{"key":"B148","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/cancers13040730","article-title":"Inflammatory mechanisms underlying nonalcoholic steatohepatitis and the transition to hepatocellular carcinoma","volume":"13","author":"Peiseler","year":"2021","journal-title":"Cancers."},{"key":"B149","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature."},{"key":"B150","doi-asserted-by":"publisher","first-page":"e0230307","DOI":"10.1371\/journal.pone.0230307","article-title":"Characterization of the immune cell landscape of patients with NAFLD","volume":"15","author":"Diedrich","year":"2020","journal-title":"PLoS ONE."},{"key":"B151","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.immuni.2016.08.015","article-title":"Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species","volume":"45","author":"Guilliams","year":"2016","journal-title":"Immunity."},{"key":"B152","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0074-7696(08)60875-X","article-title":"Cell biology and kinetics of Kupffer cells in the liver","volume":"118","author":"Wake","year":"1989","journal-title":"Int Rev Cytol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J Hepatol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2016.08.024","article-title":"Combination of mass cytometry and imaging analysis reveals origin, location, and functional repopulation of liver myeloid cells in mice","volume":"151","author":"David","year":"2016","journal-title":"Gastroenterology."},{"key":"B155","doi-asserted-by":"publisher","first-page":"G17","DOI":"10.1152\/ajpgi.1992.263.1.G17","article-title":"Evidence for Kupffer cell migration along liver sinusoids, from high-resolution in vivo microscopy","volume":"263","author":"MacPhee","year":"1992","journal-title":"Am J Physiol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J Hepatol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat Rev Immunol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1038\/s41467-018-06318-7","article-title":"Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations","volume":"9","author":"MacParland","year":"2018","journal-title":"Nat Commun."},{"key":"B159","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/gutjnl-2019-318382","article-title":"Myeloid cells in liver and bone marrow acquire a functionally distinct inflammatory phenotype during obesity-related steatohepatitis","volume":"69","author":"Krenkel","year":"2020","journal-title":"Gut."},{"key":"B160","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/hep.26607","article-title":"M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease","volume":"59","author":"Wan","year":"2014","journal-title":"Hepatology."},{"key":"B162","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut."},{"key":"B163","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1478-3231.2010.02262.x","article-title":"Acute liver failure: mechanisms of immune-mediated liver injury","volume":"30","author":"Wu","year":"2010","journal-title":"Liver Int."},{"key":"B164","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","article-title":"Macrophages: master regulators of inflammation and fibrosis","volume":"30","author":"Wynn","year":"2010","journal-title":"Semin Liver Dis."},{"key":"B165","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jhep.2014.04.026","article-title":"The role of Kupffer cells in hepatitis B and hepatitis C virus infections","volume":"61","author":"Boltjes","year":"2014","journal-title":"J Hepatol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.1074\/jbc.M115.709048","article-title":"Toll-like receptor 4 on macrophage promotes the development of steatohepatitis-related hepatocellular carcinoma in mice","volume":"291","author":"Miura","year":"2016","journal-title":"J Biol Chem."},{"key":"B168","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology."},{"key":"B170","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3109\/00365521.2012.746390","article-title":"The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients","volume":"48","author":"Lotowska","year":"2013","journal-title":"Scand J Gastroenterol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatology."},{"key":"B172","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10555-006-9001-7","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"B173","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3803\/EnM.2013.28.1.41","article-title":"Tumor necrosis factor-\u03b1 as a predictor for the development of nonalcoholic fatty liver disease: a 4-year follow-up study","volume":"28","author":"Seo","year":"2013","journal-title":"Endocrinol Metab."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.jhep.2011.01.048","article-title":"Lack of interleukin-1\u03b1 or interleukin-1\u03b2 inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice","volume":"55","author":"Kamari","year":"2011","journal-title":"J Hepatol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/13543784.2020.1681397","article-title":"A role for IL-1 inhibitors in the treatment of non-alcoholic fatty liver disease (NAFLD)?","volume":"29","author":"Tilg","year":"2020","journal-title":"Expert Opin Investig Drugs."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","article-title":"Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance","volume":"25","author":"Hung","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature."},{"key":"B178","first-page":"4545","article-title":"Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease","volume":"8","author":"Wei","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/liv.13150","article-title":"The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease","volume":"36","author":"Kazankov","year":"2016","journal-title":"Liver Int."},{"key":"B180","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/MPG.0000000000002111","article-title":"Macrophage markers are poorly associated with liver histology in children with nonalcoholic fatty liver disease","volume":"67","author":"Kazankov","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B181","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.cgh.2017.11.028","article-title":"Serum activity of macrophage-derived adenosine deaminase 2 is associated with liver fibrosis in nonalcoholic fatty liver disease","volume":"16","author":"Jiang","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/jlb.66.2.322","article-title":"Hepatic dendritic cells: immunobiology and role in liver transplantation","volume":"66","author":"Thomson","year":"1999","journal-title":"J Leukoc Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"768071","DOI":"10.1155\/2015\/768071","article-title":"The role of dendritic cells in fibrosis progression in nonalcoholic fatty liver disease","volume":"2015","author":"Almeda-Valdes","year":"2015","journal-title":"Biomed Res Int."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jhep.2013.05.033","article-title":"Dendritic cells in liver injury and fibrosis: shortcomings and promises","volume":"59","author":"Lukacs-Kornek","year":"2013","journal-title":"J Hepatol."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1053\/j.gastro.2012.06.003","article-title":"Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver","volume":"143","author":"Ibrahim","year":"2012","journal-title":"Gastroenterology."},{"key":"B186","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41423-020-00560-0","article-title":"Neutrophils in liver diseases: pathogenesis and therapeutic targets","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1002\/hep.30506","article-title":"The role of innate immune cells in nonalcoholic steatohepatitis","volume":"70","author":"Cai","year":"2019","journal-title":"Hepatology."},{"key":"B188","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1080\/01926230701584163","article-title":"Role of neutrophils in the pathogenesis of acute inflammatory liver injury","volume":"35","author":"Ramaiah","year":"2007","journal-title":"Toxicol Pathol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","article-title":"The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)","volume":"17","author":"Nati","year":"2016","journal-title":"Rev Endocr Metab Disord."},{"key":"B190","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","article-title":"Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C","volume":"26","author":"Tanwar","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B191","doi-asserted-by":"publisher","first-page":"625472","DOI":"10.3389\/fimmu.2021.625472","article-title":"The roles of neutrophils in the pathogenesis of liver diseases","volume":"12","author":"Tang","year":"2021","journal-title":"Front Immunol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/MEG.0000000000001393","article-title":"Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease","volume":"31","author":"Khoury","year":"2019","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00535-010-0272-y","article-title":"Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet","volume":"45","author":"Miyagi","year":"2010","journal-title":"J Gastroenterol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/hep.29914","article-title":"Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis","volume":"68","author":"van der Windt","year":"2018","journal-title":"Hepatology."},{"key":"B195","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s10020-019-0084-3","article-title":"Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes","volume":"25","author":"Mirea","year":"2019","journal-title":"Mol Med."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med."},{"key":"B197","doi-asserted-by":"publisher","first-page":"640869","DOI":"10.3389\/fimmu.2021.640869","article-title":"Revisiting the role of natural killer cells in non-alcoholic fatty liver disease","volume":"12","author":"Martinez-Chantar","year":"2021","journal-title":"Front Immunol."},{"key":"B198","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science."},{"key":"B199","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","article-title":"NKG2D and its ligands: \u201cone for all, all for one\u201d","volume":"9","author":"Zingoni","year":"2018","journal-title":"Front Immunol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/JLB.2A0118-031RR","article-title":"Activated NK cells kill hepatic stellate cells via p38\/PI3K signaling in a TRAIL-involved degranulation manner","volume":"105","author":"Li","year":"2019","journal-title":"J Leukocyte Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","article-title":"NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis","volume":"61","author":"Gur","year":"2012","journal-title":"Gut."},{"key":"B202","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","article-title":"Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners","volume":"130","author":"Radaeva","year":"2006","journal-title":"Gastroenterology."},{"key":"B203","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/hep.23253","article-title":"Major histocompatibility complex class I-related chains A and B (MIC A\/B): a novel role in nonalcoholic steatohepatitis","volume":"51","author":"Kahraman","year":"2010","journal-title":"Hepatology."},{"key":"B204","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/hep4.1146","article-title":"Insulin signaling as a potential natural killer cell checkpoint in fatty liver disease","volume":"2","author":"Amer","year":"2018","journal-title":"Hepatol Commun."},{"key":"B205","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat Immunol."},{"key":"B206","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41467-018-04450-y","article-title":"Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver","volume":"9","author":"Hegde","year":"2018","journal-title":"Nat Commun."},{"key":"B207","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3389\/fimmu.2018.01994","article-title":"Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3748\/wjg.14.487","article-title":"Natural killer T cells and non-alcoholic fatty liver disease: fat chews on the immune system","volume":"14","author":"Kremer","year":"2008","journal-title":"World J Gastroenterol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"Syn","year":"2012","journal-title":"Gut."},{"key":"B210","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.4049\/jimmunol.1800614","article-title":"Differential activation of hepatic invariant NKT cell subsets plays a key role in progression of nonalcoholic steatohepatitis","volume":"201","author":"Maricic","year":"2018","journal-title":"J Immunol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/path.1869","article-title":"Amelioration of non-alcoholic steatohepatitis and glucose intolerance in ob\/ob mice by oral immune regulation towards liver-extracted proteins is associated with elevated intrahepatic NKT lymphocytes and serum IL-10 levels","volume":"208","author":"Elinav","year":"2006","journal-title":"J Pathol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"e80949","DOI":"10.1371\/journal.pone.0080949","article-title":"Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding","volume":"9","author":"Martin-Murphy","year":"2014","journal-title":"PLoS ONE."},{"key":"B213","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-065X.1997.tb01008.x","article-title":"Alpha beta and gamma delta T-cell networks and their roles in natural resistance to viral infections","volume":"159","author":"Welsh","year":"1997","journal-title":"Immunol Rev."},{"key":"B214","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4291\/wjgp.v5.i2.107","article-title":"Role of gamma-delta T cells in liver inflammation and fibrosis","volume":"5","author":"Hammerich","year":"2014","journal-title":"World J Gastrointest Pathophysiol."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3389\/fimmu.2020.01500","article-title":"Roles of hepatic innate and innate-like lymphocytes in nonalcoholic steatohepatitis","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"13839","DOI":"10.1038\/ncomms13839","article-title":"The microbiota maintain homeostasis of liver-resident \u03b3\u03b4T-17 cells in a lipid antigen\/CD1d-dependent manner","volume":"8","author":"Li","year":"2017","journal-title":"Nat Commun."},{"key":"B217","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/hep.30952","article-title":"\u03b3\u03b4 T Cells promote steatohepatitis by orchestrating innate and adaptive immune programming","volume":"71","author":"Torres-Hernandez","year":"2020","journal-title":"Hepatology"},{"key":"B218","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: an emerging player in the progression of NAFLD","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.freeradbiomed.2018.06.015","article-title":"B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)","volume":"124","author":"Bruzz\u00ec","year":"2018","journal-title":"Free Rad Biol Med."},{"key":"B220","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fimmu.2019.00082","article-title":"The differential roles of t cells in non-alcoholic fatty liver disease and obesity","volume":"10","author":"Van Herck","year":"2019","journal-title":"Front Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1042\/CS20150405","article-title":"The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice","volume":"130","author":"Rolla","year":"2016","journal-title":"Clin Sci (Lond)."},{"key":"B222","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1002\/hep.26749","article-title":"Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH","volume":"59","author":"Sutti","year":"2014","journal-title":"Hepatology"},{"key":"B223","doi-asserted-by":"publisher","first-page":"G891","DOI":"10.1152\/ajpgi.00193.2013","article-title":"IFN-\u03b3 deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet","volume":"305","author":"Luo","year":"2013","journal-title":"Am J Physiol Gastrointestinal Liver Physiol."},{"key":"B224","doi-asserted-by":"publisher","first-page":"e13577","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PLoS ONE."},{"key":"B225","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s10875-011-9571-1","article-title":"Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis","volume":"31","author":"Inzaugarat","year":"2011","journal-title":"J Clin Immunol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","article-title":"Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory t cell ratio in peripheral blood and in the liver","volume":"196","author":"Rau","year":"2016","journal-title":"J Immunol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1002\/hep.26746","article-title":"IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice","volume":"59","author":"Harley","year":"2014","journal-title":"Hepatology."},{"key":"B228","doi-asserted-by":"publisher","first-page":"154497","DOI":"10.1016\/j.cyto.2018.07.028","article-title":"Type 3 cytokines in liver fibrosis and liver cancer","volume":"124","author":"Molina","year":"2019","journal-title":"Cytokine."},{"key":"B229","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology."},{"key":"B230","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep4.1041","article-title":"Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis","volume":"1","author":"Bhattacharjee","year":"2017","journal-title":"Hepatol Commun."},{"key":"B231","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell."},{"key":"B232","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.167.1.21","article-title":"Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients","volume":"167","author":"Racanelli","year":"2001","journal-title":"J Immunol."},{"key":"B233","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/hep.27761","article-title":"Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity","volume":"61","author":"Thapa","year":"2015","journal-title":"Hepatology."},{"key":"B234","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s12072-012-9345-8","article-title":"B cell-activating factor is associated with the histological severity of nonalcoholic fatty liver disease","volume":"7","author":"Miyake","year":"2013","journal-title":"Hepatol Int."},{"key":"B235","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.jhep.2014.01.010","article-title":"Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"McPherson","year":"2014","journal-title":"J Hepatol."},{"key":"B236","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B237","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/liv.14844","article-title":"New drugs for NASH","volume":"41","author":"Albhaisi","year":"2021","journal-title":"Liver Int."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology."},{"key":"B239","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.livres.2020.02.003","article-title":"The alteration of immune cells in the pathogenesis of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"4","author":"Feng","year":"2020","journal-title":"Liver Res."},{"key":"B240","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antiox7010012","article-title":"Vitamin E as a treatment for nonalcoholic fatty liver disease: reality or myth?","volume":"7","author":"El Hadi","year":"2018","journal-title":"Antioxidants."},{"key":"B241","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/13543784.2018.1442436","article-title":"Cenicriviroc for the treatment of non-alcoholic steatohepatitis and liver fibrosis","volume":"27","author":"Tacke","year":"2018","journal-title":"Exp Opin Investig Drugs."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology."},{"key":"B243","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hep.31108","article-title":"Cenicriviroc treatment for adults with nonalcoholic steatohepatitis and fibrosis: final analysis of the phase 2b CENTAUR study","volume":"72","author":"Ratziu","year":"2020","journal-title":"Hepatology."},{"key":"B244","doi-asserted-by":"publisher","first-page":"105922","DOI":"10.1016\/j.cct.2019.105922","article-title":"Cenicriviroc for the treatment of liver fibrosis in adults with nonalcoholic steatohepatitis: AURORA Phase 3 study design","volume":"89","author":"Anstee","year":"2020","journal-title":"Contemp Clin Trials."},{"key":"B245","unstructured":""},{"key":"B246","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2019.11.296","article-title":"Effects of belapectin, an inhibitor of galectin-3, in patients with nonalcoholic steatohepatitis with cirrhosis and portal hypertension","volume":"158","author":"Chalasani","year":"2020","journal-title":"Gastroenterology."},{"key":"B247","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/ijms19020379","article-title":"Galectin-3: one molecule for an alphabet of diseases, from A to Z","volume":"19","author":"Sciacchitano","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B248","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/glycob\/cwn104","article-title":"Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils","volume":"19","author":"Karlsson","year":"2008","journal-title":"Glycobiology."},{"key":"B249","doi-asserted-by":"publisher","first-page":"5060","DOI":"10.1073\/pnas.0511167103","article-title":"Galectin-3 regulates myofibroblast activation and hepatic fibrosis","volume":"103","author":"Henderson","year":"2006","journal-title":"Proc Natl Acad Sci USA."},{"key":"B250","doi-asserted-by":"publisher","first-page":"e83481","DOI":"10.1371\/journal.pone.0083481","article-title":"Therapy of experimental NASH and fibrosis with galectin inhibitors","volume":"8","author":"Traber","year":"2013","journal-title":"PLoS ONE."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/apt.13816","article-title":"Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis","volume":"44","author":"Harrison","year":"2016","journal-title":"Alimentary Pharmacol Therap."},{"key":"B252","unstructured":""},{"key":"B253","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell."},{"key":"B254","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/hep.27982","article-title":"CX3CR1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis","volume":"62","author":"Schneider","year":"2015","journal-title":"Hepatology."},{"key":"B255","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol."},{"key":"B256","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3945\/ajcn.113.068890","article-title":"Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study","volume":"99","author":"Eslamparast","year":"2014","journal-title":"Am J Clin Nutr."},{"key":"B257","doi-asserted-by":"publisher","first-page":"41","DOI":"10.15403\/jgld.2014.1121.271.kby","article-title":"A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial","volume":"27","author":"Kobyliak","year":"2018","journal-title":"J Gastrointestin Liver Dis."},{"key":"B258","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","article-title":"Roles for chemokines in liver disease","volume":"147","author":"Marra","year":"2014","journal-title":"Gastroenterology."},{"key":"B259","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.omtm.2016.11.004","article-title":"Antibody-directed glucocorticoid targeting to CD163 in M2-type macrophages attenuates fructose-induced liver inflammatory changes","volume":"4","author":"Svendsen","year":"2017","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B260","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.biomaterials.2014.10.030","article-title":"Fluorescent cell-traceable dexamethasone-loaded liposomes for the treatment of inflammatory liver diseases","volume":"37","author":"Bartneck","year":"2015","journal-title":"Biomaterials."},{"key":"B261","doi-asserted-by":"publisher","first-page":"9636897211004090","DOI":"10.1177\/09636897211004090","article-title":"Infusion of kupffer cells expanded in","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transplant."},{"key":"B262","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","article-title":"Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function","volume":"53","author":"Thomas","year":"2011","journal-title":"Hepatology."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.jcyt.2015.07.016","article-title":"Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study","volume":"17","author":"Moore","year":"2015","journal-title":"Cytotherapy."},{"key":"B264","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/S0168-8278(18)30425-2","article-title":"JKB-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study","volume":"68","author":"Diehl","year":"2018","journal-title":"J Hepatol."},{"key":"B265","unstructured":""},{"key":"B266","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/jcm9041140","article-title":"The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis","volume":"9","author":"Puengel","year":"2020","journal-title":"J Clin Med."},{"key":"B267","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1007\/s00394-017-1456-5","article-title":"Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets","volume":"57","author":"Du Toit","year":"2018","journal-title":"Eur J Nutr."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2005-11-4599","article-title":"Developmental regulation of the adhesive and enzymatic activity of vascular adhesion protein-1 (VAP-1) in humans","volume":"108","author":"Salmi","year":"2006","journal-title":"Blood."},{"key":"B269","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J Clin Investig."},{"key":"B270","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4254\/wjh.v12.i11.931","article-title":"Inhibition of vascular adhesion protein-1 modifies hepatic steatosis in vitro and in vivo.","volume":"12","author":"Shepherd","year":"2020","journal-title":"World J Hepatol"},{"key":"B271","unstructured":""},{"key":"B272","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/cei.13159","article-title":"Immunotherapy with oral administration of humanized anti-CD3 monoclonal antibody: a novel gut-immune system-based therapy for meta-inflammation and NASH","volume":"193","author":"Ilan","year":"2018","journal-title":"Clin Exp Immunol."},{"key":"B273","doi-asserted-by":"publisher","first-page":"9765","DOI":"10.1073\/pnas.0908771107","article-title":"Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob\/ob mice","volume":"107","author":"Ilan","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B274","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10875-015-0160-6","article-title":"Oral administration of OKT3 MAb to patients with NASH, promotes regulatory T-cell induction, and alleviates insulin resistance: results of a phase IIa blinded placebo-controlled trial","volume":"35","author":"Lalazar","year":"2015","journal-title":"J Clin Immunol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.781567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T10:40:31Z","timestamp":1639046431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.781567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":274,"alternative-id":["10.3389\/fmed.2021.781567"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.781567","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,9]]},"article-number":"781567"}}